Search research articles
Contact Us
Filters
Showing results (161-170 of 308) with videos related to
Page
of 31
Sort By:
Allergy
|
February 17, 2022
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
Milena Sokolowska, G Enrico Rovati, Zuzana Diamant, et al.
International Forum of Allergy & Rhinology
|
January 6, 2026
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)
Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 29, 2022
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies
Claus Bachert, Anju T Peters, Enrico Heffler, et al.
International Forum of Allergy & Rhinology
|
April 17, 2026
Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)
Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Allergy
|
July 14, 2023
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
Jasper Kappen, Zuzana Diamant, Ioana Agache, et al.
Allergy
|
February 5, 2025
Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial
Stefan Zielen, Jonathan A Bernstein, Gunter J Sturm, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 8, 2025
Comparing allergic rhinitis treatments based on patient satisfaction: A MASK-air® study
Rafael José Vieira, Bernardo Sousa-Pinto, Sara Gil-Mata, et al.
The Journal of Allergy and Clinical Immunology
|
September 6, 2025
Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy
Mohamed H Shamji, William T Fulton, Ibrahim Animashaun, et al.
Recenti Progressi in Medicina
|
July 15, 2021
[ARIA (Allergic Rhinitis and its Impact on Asthma) 2019. Treatments for allergic rhinitis - Italy.]
Giovanni Passalacqua, Lorenzo Cecchi, Giorgio Walter Canonica, et al.
Allergy
|
July 9, 2025
Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position Paper
Adam Chaker, Paula Kauppi, Sevim Bavbek, et al.
Page
of 31
Search research articles
Search
Showing results (161-170 of 308) with videos related to
Sort By:
Page
of 31
Allergy
|
February 17, 2022
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
Milena Sokolowska, G Enrico Rovati, Zuzana Diamant, et al.
International Forum of Allergy & Rhinology
|
January 6, 2026
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)
Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 29, 2022
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies
Claus Bachert, Anju T Peters, Enrico Heffler, et al.
International Forum of Allergy & Rhinology
|
April 17, 2026
Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)
Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Allergy
|
July 14, 2023
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
Jasper Kappen, Zuzana Diamant, Ioana Agache, et al.
Allergy
|
February 5, 2025
Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial
Stefan Zielen, Jonathan A Bernstein, Gunter J Sturm, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 8, 2025
Comparing allergic rhinitis treatments based on patient satisfaction: A MASK-air® study
Rafael José Vieira, Bernardo Sousa-Pinto, Sara Gil-Mata, et al.
The Journal of Allergy and Clinical Immunology
|
September 6, 2025
Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy
Mohamed H Shamji, William T Fulton, Ibrahim Animashaun, et al.
Recenti Progressi in Medicina
|
July 15, 2021
[ARIA (Allergic Rhinitis and its Impact on Asthma) 2019. Treatments for allergic rhinitis - Italy.]
Giovanni Passalacqua, Lorenzo Cecchi, Giorgio Walter Canonica, et al.
Allergy
|
July 9, 2025
Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position Paper
Adam Chaker, Paula Kauppi, Sevim Bavbek, et al.
Page
of 31